WU, J. .; BALU, S.; BIRK LARSEN, N. .; PULLEYBLANK, R. .; STRØMKJÆR, L.; QUAH, A.; WISEMAN, M. . Cost-per-Responder Analysis of Tralokinumab versus Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis in the US and Canada. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 1, p. s317, 2024. DOI: 10.25251/skin.8.supp.317. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/2397. Acesso em: 3 jul. 2024.